Table 4 Evaluation of the agreement between the results by protocol targets using the Cohen’s Kappa agreement coefficient
Protocol | BERLIN | HKU | DAAN Gene® | IPP | |||||
|---|---|---|---|---|---|---|---|---|---|
Protocol | Target | BERLIN E | BERLIN RdRp | HKU N | HKU Orf1b | DAAN Gene® N | DAAN Gene® Orf1ab | IPP IP2 | IPP IP4 |
BERLIN | BERLIN E | 1 | |||||||
BERLIN RdRp | 0.732 95% CI [0.617–0.848] | 1 | |||||||
HKU | HKU N | 0.713 95% CI [0.591–0.836] | 0.668 95% CI [0.539–0.796] | 1 | |||||
HKU Orf | 0.476 95% CI [0.324–0.628] | 0.547 95% CI [0.399–0.694] | 0.732 95% CI [0.615–0.848] | 1 | |||||
DAAN Gene® | DAAN Gene® N | − 0.012 95% CI [− 0.104 to 0.080] | 0.022 95% CI [− 0.054 to 0.098] | 0.455 95% CI [0.305–0.604] | − 0.041 95% CI [− 0.119 to 0.037] | 1 | |||
DAAN Gene® Orf1ab | 0.476 95% CI [0.324–0.628] | 0.463 95% CI [0.325–0.601] | 0.455 95% CI [0.305–0.604] | 0.353 95% CI [0.213–0.493] | 0.156 95% CI [0.025–0.287] | 1 | |||
IPP | IPP IP2 | 0.681 95% CI [0.554–0.809] | 0.541 95% CI [0.396–0.686] | 0.587 95% CI [0.445–0.728] | 0.542 95% CI [0.399–0.685] | − 0.036 95% CI [− 0.123–0.051] | 0.391 95% CI [0.236–0.545] | 1 | |
IPP IP4 | 0.240 95% CI [0.102–0.370] | 0.011 95% CI [− 0.150 to 0.172] | 0.124 95% CI [− 0.025 to 0.274] | − 0.056 95% CI [− 0.219 to 0.106] | − 0.006 95% CI [− 0.060 to 0.048] | 0.117 95% CI [− 0.002 to 0.237] | 0.312 95% CI [0.169–0.454] | 1 | |